Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesGender-Affirming CareAetna Gender-Affirming Surgery Coverage Update | O…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentAetnaPolicy 0615

    Gender Affirming Surgery

    Customize your policy alerts

    Sign up for Aetna Policy 0615 alerts

    Get alerted when Policy 0615 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This Clinical Policy Bulletin governs medical necessity criteria, covered and not-covered gender-affirming surgical procedures and related services for Aetna members; applicability may vary by specific benefit plan.

    Policy Summary
    PayerAetna
    PolicyGender Affirming Surgery
    Policy CodePolicy 0615
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain a signed letter from a qualified mental health professional and documentation of marked and sustained gender dysphoria to support medical necessity for gender-affirming surgery.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    extensivecodes enumerated
    >=6 monthshormone therapy prerequisite
    93%vaginoplasty satisfaction
    48.9%phalloplasty urethral complications

    Medical Necessity and Coverage Criteria

    Medical necessity criteria by procedure group

    Aetna considers gender affirming surgery medically necessary when criteria for each of the following procedures is met:

    Breast Removal Requirements: 1) Signed letter from a qualified mental health professional assessing readiness for physical treatment; 2) Documentation of marked and sustained gender dysphoria; 3) Other possible causes of apparent gender incongruence have been excluded; 4) Mental and physical health conditions that could negatively impact outcome are assessed and risks/benefits discussed; 5) Capacity to consent for the specific physical treatment; 6) For members <18 years, completion of one year of testosterone treatment unless hormone therapy is not desired or medically contraindicated; 7) Risk factors associated with breast cancer have been assessed.
    Breast Augmentation Requirements: 1) Signed letter from a qualified mental health professional assessing readiness for physical treatments; 2) Documentation of marked and sustained gender dysphoria; 3) Other possible causes of apparent gender incongruence have been excluded; 4) Mental and physical health conditions that could negatively impact outcome are assessed and risks/benefits discussed; 5) Capacity to consent for the specific physical treatment; 6) Completion of six months of feminizing hormone therapy (12 months for adolescents <18) prior to breast augmentation surgery unless hormone therapy is not desired or medically contraindicated; 7) Risk factors associated with breast cancer have been assessed.
    Policy Summary
    PayerAetna
    PolicyGender Affirming Surgery
    Policy CodePolicy 0615
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain a signed letter from a qualified mental health professional and documentation of marked and sustained gender dysphoria to support medical necessity for gender-affirming surgery.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCPT / HCPCS / ICD-10 Codes and Related Coding NotesAuthorization, Documentation, and Billing Guidance for ProvidersClinical Background and Evidence SummaryKey Definitions and Diagnostic Criteria
    Gonadectomy Requirements: 1) Signed letter from a qualified mental health professional assessing readiness for physical treatments; 2) Documentation of marked and sustained gender dysphoria; 3) Other possible causes of apparent gender incongruence have been excluded; 4) Mental and physical health conditions that could negatively impact outcome are assessed and risks/benefits discussed; 5) Capacity to consent for the specific physical treatment; 6) Six months of continuous hormone therapy as appropriate to the member's gender goals (12 months for adolescents <18), unless hormone therapy is not desired or medically contraindicated.
    Genital Reconstructive Surgery Requirements: 1) Signed letter from a qualified mental health professional assessing readiness for physical treatments; 2) Documentation of marked and sustained gender dysphoria; 3) Other possible causes of apparent gender incongruence have been excluded; 4) Mental and physical health conditions that could negatively impact outcome are assessed and risks/benefits discussed; 5) Capacity to consent for the specific physical treatment; 6) Six months of continuous hormone therapy as appropriate to the member's gender goals (12 months for adolescents <18), unless hormone therapy is not desired or medically contraindicated.

    Clinical background and preparatory recommendations

    Background clinical considerations referenced in document (no discrete coverage criteria in this section):

    Clinical prerequisites: Gender-affirming surgery is delivered as part of multidisciplinary care; psychological adjustment and mental health care are integral and may continue postoperatively. Hormone therapy is recommended prior to some procedures (for example, minimum six months of feminizing hormones before breast augmentation) to optimize outcomes. The criteria above reflect assessment of readiness, exclusion of other causes, evaluation of mental and physical health risks, and capacity to consent.

    Descriptive background rather than prescriptive criteria.

    Aetna considers the following procedures commonly performed as part of gender transition to be not medically necessary (cosmetic), unless otherwise specified by plan benefits: most hair removal (e.g., electrolysis, laser hair removal) except a limited number of sessions for skin graft preparation for genital surgery; tracheal shave (reduction thyroid chondroplasty); and many facial gender-affirming procedures including brow procedures, hairline advancement/hair transplant, facelift/mid-face lift (platysmaplasty), blepharoplasty, rhinoplasty (with or without fillers), cheek augmentation (implant or lipofilling), lip procedures (augmentation or shortening), lower jaw procedures, and chin reshaping (osteoplastic or implant-based). Body contouring procedures such as liposuction, implants (pectoral, hip, gluteal, calf) and related cosmetic procedures are also listed as not medically necessary when performed solely for gender affirmation.

    Do not bill CPT 19303 (mastectomy for breast cancer) for chest masculinization/reduction mammaplasty in female-to-male (transmasculine) gender-affirming surgery. CPT guidance specifies that 19303 is intended for treatment or prevention of breast cancer and describes total removal of breast tissue; routine gender-affirming chest procedures typically preserve the nipple–areola complex and have different surgical objectives and documentation requirements.

    Aetna considers more than one breast augmentation to be not medically necessary. This exclusion does not apply to medically necessary replacement of breast implants (for example, for device failure or complication) where replacement is documented as clinically indicated.

    Coverage for facial gender-affirming surgery (FGAS) is variable across payers. Systematic review data show many commercial and Medicaid policies consider FGAS cosmetic; only a minority of state Medicaid programs include FGAS and many commercial policies either exclude or treat these procedures as cosmetic despite near-universal coverage for genital reconstruction in reviewed commercial policies.

    CPT / HCPCS / ICD-10 Codes and Related Coding Notes

    Covered CPT CodesCPTCovered
    13131Repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; 1.1 cm to 2.5 cm.
    13132Repair, complex; 2.6 cm to 7.5 cm.
    13133Repair, complex; each additional 5 cm or less.
    13160Secondary closure of surgical wound or dehiscence, extensive or complicated.
    14021Adjacent tissue transfer or rearrangement, scalp, arms and/or legs; defect 10.1 sq cm to 30.0 sq cm.
    14040Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less.
    14041Adjacent tissue transfer or rearrangement; defect 10.1 sq cm to 30.0 sq cm.
    14301Adjacent tissue transfer or rearrangement, any area; defect 30.1 sq cm to 60.0 sq cm.
    14302Adjacent tissue transfer or rearrangement, any area; each additional 30.0 sq cm, or part thereof.
    15002-15003Surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar; trunk, arms, legs; first 100 sq cm or 1% of body area of infants and children.
    1–10 of 89
    1/9
    CPT Codes Not Covered / CosmeticCPTNot Covered
    11950-11954Subcutaneous injection of filling material (e.g., collagen) - cosmetic/not covered.
    15200Full thickness graft, free, trunk; 20 sq cm or less [nipple reconstruction] - not covered when cosmetic.
    15775Punch graft for hair transplant; 1 to 15 punch grafts - not covered.
    15776Punch graft for hair transplant; more than 15 punch grafts - not covered.
    15780-15787Dermabrasion - not covered.
    15788-15793Chemical peel - not covered.
    15820-15823Blepharoplasty - not covered.
    15824-15828Rhytidectomy (face-lifting) - not covered.
    15830-15839Excision, excessive skin and subcutaneous tissue; abdomen, infraumbilical panniculectomy - not covered.
    15876-15879Suction assisted lipectomy - not covered.
    1–10 of 23
    1/3
    Covered HCPCS / Drug / Prosthesis CodesHCPCSCovered
    C1789Prosthesis, breast (implantable).
    C1813Prosthesis, penile, inflatable.
    C2622Prosthesis, penile, non-inflatable.
    J1071Injection, testosterone cypionate, 1 mg.
    J3121Injection, testosterone enanthate, 1 mg.
    J3145Injection, testosterone undecanoate, 1 mg.
    J1950Injection, leuprolide acetate (for depot suspension), per 3.75 mg.
    J9202Goserelin acetate implant, per 3.6 mg.
    J9217Leuprolide acetate (for depot suspension), 7.5 mg.
    J9218Leuprolide acetate, per 1 mg.
    1–10 of 13
    1/2
    ICD-10 CodesICD-10Covered
    F64.0-F64.9Gender identity disorders.
    Z87.890Personal history of sex reassignment.
    Notes on breast/chest procedure CPT codes and incidental editsmixed
    Note1CPT codes for mastectomy (eg, 19303) are for breast cancer and are not appropriate to bill for reduction mammaplasty for female-to-male gender affirmation surgery.
    Note2CPT 19318 (reduction mammaplasty) includes repositioning and reshaping of the nipple; CPT 19350 (nipple reconstruction) is incidental to 19318 and is generally not separately billable when performed at time of 19318.
    Note3Graft codes (eg, 15200) and liposuction codes (eg, 15877) may be CCI 'incidental to' edits to 19318 and are included in 19318 when applicable.
    Hormone therapy duration (prerequisite durations)
    Hormone therapy duration (prerequisite durations)Six months of continuous hormone therapy as appropriate to the member's gender goals (12 months for adolescents <18 years) prior to many gender-affirming surgeries; breast augmentation requires 6 months feminizing hormones (12 months for adolescents <18).
    Gender dysphoria duration for diagnosis
    Gender dysphoria duration for diagnosisDiagnosis of gender dysphoria requires a marked difference between experienced and assigned gender that continues for at least six months.

    Authorization, Documentation, and Billing Guidance for Providers

    Prior Authorization

    Prior Authorization Required and Coverage Variability

    Prior authorization is required for the gender-affirming procedures listed in the CPT/HCPCS code sections when applicable and when medical-necessity criteria in this policy are not clearly met. Coverage and prior authorization requirements vary by payer and by the member’s specific benefit plan; always verify benefits before scheduling.

    • Prior authorization required for listed CPT/HCPCS codes when medical necessity criteria are not met or unclear
    • Coverage varies by plan — check member-specific benefits and plan exclusions
    Note

    Coverage Determined by Plan Benefits

    Authorization and coverage determinations are governed by the member’s benefit plan terms. Even when procedures meet the medical necessity criteria in this policy, coverage is subject to the member’s contract, plan limits, and any applicable Clinical Policy Bulletins (CPBs).

    • Benefits, limits, and exclusions in the member’s evidence of coverage control payment
    • Clinical Policy Bulletins may further define coverage — verify applicability to the member’s plan
    Denial Risk

    Denial Triggers — Cosmetic or Not Medically Necessary

    Services that are cosmetic or otherwise not medically necessary per this policy will be denied. Examples include procedures identified as cosmetic in the policy (e.g., routine facial gender-affirming procedures considered cosmetic, hair removal except for limited preoperative graft preparation, and multiple breast augmentations beyond medically necessary replacement).

    • Claims for procedures listed as cosmetic or not medically necessary may be denied
    • Elective procedures without documented medical necessity or required documentation are denial triggers
    Billing Rule

    Incorrect CPT Use for Mastectomy (Billing Guidance)

    Do not routinely bill mastectomy codes intended for breast cancer (e.g., CPT 19303) for chest masculinization (female-to-male) procedures. Reduction mammaplasty codes (e.g., CPT 19318) describe the work typically performed for chest masculinization and include nipple/areola work that may be incidental to the procedure; use the code that accurately reflects the work performed.

    • CPT 19303 is for breast cancer-related mastectomy and is not appropriate for gender-affirming chest procedures
    • Use CPT 19318 (reduction mammaplasty) or other codes that reflect performed work for transmasculine chest surgery
    Billing Rule

    Incorrect Use of Nipple Reconstruction Code (Billing Guidance)

    Do not report CPT 19350 (nipple/areola reconstruction) at the same operative session when the work performed is included in the primary reduction/mastectomy/reconstruction code (e.g., CPT 19318). CPT 19350 describes a separate, more involved nipple construction and is generally an incidental-to edit when billed with codes such as 19318.

    • CPT 19350 is typically incidental to CPT 19318 and should not be separately reported when nipple/areola modification is part of the primary procedure
    • When true nipple reconstruction as defined by CPT 19350 is performed as a distinct procedure, document the additional work to support separate reporting
    Documentation Required

    Procedure-Specific Documentation Requirements

    Provide procedure-specific documentation to support the chosen CPT/HCPCS code(s) and to describe the extent of work performed. Include operative reports that detail surgical technique, structures addressed, and any grafting or implant work to justify the selected codes.

    • Operative report describing technique, tissues removed or preserved, grafts, implants, and intraoperative findings
    • If unlisted codes are used, include detailed operative note and rationale for code selection
    Documentation Required

    Mental Health Evaluation and Provider Qualifications

    A signed letter from a qualified mental health professional documenting readiness for physical treatments and assessment of marked and sustained gender dysphoria is required for most gender-affirming surgeries. The mental health professional must meet the qualifications described in the Appendix (WPATH SOC-8 guidance).

    • Signed readiness assessment letter from a qualified mental health professional (see Appendix for qualifications)
    • Documentation of marked and sustained gender dysphoria per DSM-5 criteria
    Documentation Required

    Surgical and Adolescent Provider Qualifications

    Surgeons performing gender-affirming procedures should have documented training and experience in gender-affirming surgery, maintain an active practice and outcome tracking, and engage in continuing education per WPATH SOC-8. Providers who treat adolescents must meet the Appendix qualifications for adolescent care.

    • Surgeon documentation of training/supervision in gender-affirming procedures and maintenance of active practice
    • Adolescent care providers should have postgraduate pediatric/adolescent expertise and training in gender identity development
    Documentation Required

    Hormone Therapy Prerequisites (Provider Action)

    Hormone therapy prerequisites must be documented when required by the procedure-specific criteria: typically six months of continuous hormone therapy for adults (12 months for adolescents under 18) as appropriate to the member’s gender goals, unless hormone therapy is not desired or is medically contraindicated.

    • Document duration and type of hormone therapy when required (e.g., 6 months feminizing therapy prior to breast augmentation; 6 months appropriate therapy for other procedures)
    • If hormone therapy was not desired or was medically contraindicated, include documentation supporting that exception
    Prior Authorization

    Preoperative Hormone Therapy Recommendation for Breast Augmentation

    For transfeminine persons undergoing breast augmentation, document completion of feminizing hormone therapy for a minimum of six months prior to augmentation (12 months for adolescents), unless hormones are not desired or medically contraindicated. This preoperative hormone therapy is recommended to maximize breast growth and optimize surgical results.

    • Record start and end dates of feminizing hormone therapy and any clinical rationale for exceptions
    • Preoperative hormone therapy documentation supports clinical decision-making and prior authorization reviews
    Documentation Required

    Required Clinical Documentation for Authorization

    Include the following required clinical documentation with requests for authorization: signed mental health readiness letter, documentation of marked and sustained gender dysphoria (DSM-5 criteria), exclusion of other causes of incongruence, assessment of mental/physical comorbidities and capacity to consent, and cancer-risk assessment when applicable. For adolescents, include documentation of hormone therapy duration or contraindication.

    • Signed readiness letter from qualified mental health professional
    • DSM-5–based documentation of marked and sustained gender dysphoria
    • Assessment of other causes, comorbidities, capacity to consent, and cancer risk factors
    • Hormone therapy documentation or rationale for exceptions for adolescents
    Note

    Coverage Administration Note

    Coverage decisions and prior authorization processing are administered per the member’s benefit plan and may be further informed by Clinical Policy Bulletins (CPBs). Always reference the applicable CPBs and the member’s plan documents when determining coverage eligibility.

    • Verify applicability of related CPBs (e.g., implant removal, cosmetic surgery) to the member’s claim
    • Confirm member-specific plan coverage, exclusions, and prior authorization pathways

    Clinical Background and Evidence Summary

    Gender dysphoria describes the distress or discomfort resulting from incongruence between an individual’s experienced gender and the gender assigned at birth; diagnostic criteria require a marked difference that is persistent for at least 6 months and is associated with clinically significant distress or impairment. Gender-affirming surgery encompasses procedures to change primary and/or secondary sex characteristics (for example, vaginoplasty, phalloplasty, mastectomy, breast augmentation, and facial procedures) and is delivered as part of multidisciplinary care; psychological evaluation and mental health support are integral to preparation and may continue postoperatively.

    Clinical background and preparatory recommendations (also relevant here for context)

    Background clinical considerations referenced in document (no discrete coverage criteria in this section):

    Clinical prerequisites: Gender-affirming surgery is performed to change primary and/or secondary sex characteristics. Transfeminine procedures may include genital reconstruction, breast augmentation, and various cosmetic procedures; transmasculine procedures may include mastectomy, phalloplasty, hysterectomy and oophorectomy, and chest contouring. Psychological adjustment is necessary alongside medical/surgical interventions; mental health care may need continuation after surgery.

    Contextual background to inform clinical decision-making and documentation.

    Key Definitions and Diagnostic Criteria

    Gender dysphoria definition (short)
    Short definitionDiscomfort or distress caused by a discrepancy between an individual’s gender identity and the gender assigned at birth; diagnosis requires a marked difference that continues for at least six months.
    Clinical relevanceMay cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
    Source guidanceDefinition aligned with DSM-5-TR and referenced guidance from WPATH SOC-8.
    Gender dysphoria definition (duplicate/explanatory)
    Expanded definitionGender dysphoria refers to discomfort or distress caused by discrepancy between an individual’s gender identity and the gender assigned at birth (including associated gender role and/or primary and secondary sex characteristics); diagnosis requires a marked incongruence persisting at least six months.
    Functional impactThis condition may result in clinically significant distress or impairment in social, occupational, or other important areas of functioning.
    Contextual noteWPATH SOC-8 recognizes gender incongruence and emphasizes that distress may be addressed with gender-affirming treatments; nomenclature and classifications across ICD and DSM may differ.
    Gender-affirming surgery definition
    DefinitionGender-affirming surgery: surgical procedures performed to change primary and/or secondary sex characteristics (examples include vaginoplasty, phalloplasty, mastectomy, breast augmentation, hysterectomy, oophorectomy, orchiectomy, facial feminization, voice surgery, and related reconstructive procedures).
    PurposePerformed to align an individual’s physical characteristics with their gender identity and may be part of multidisciplinary care including hormones and mental health support.
    Procedure examplesTransfeminine examples: vaginoplasty, breast augmentation, penectomy, orchidectomy; Transmasculine examples: mastectomy, phalloplasty, hysterectomy, oophorectomy; also cosmetic procedures such as facial reshaping and voice modification.
    DSM-5 Gender Dysphoria (Adults and Adolescents) criteria summary
    Core DSM-5 criteria summaryMarked incongruence between experienced/expressed gender and assigned gender of at least six months duration, manifested by two or more specified criteria (e.g., incongruence with primary/secondary sex characteristics; strong desire to be rid of one’s primary/secondary sex characteristics; strong desire for characteristics of the other gender; strong desire to be of the other gender; desire to be treated as the other gender; strong conviction of having typical feelings of the other gender).
    Associated impairmentThe condition must be associated with clinically significant distress or impairment in social, occupational, or other important areas of functioning.
    Assessment noteThere is no minimum duration of relationship required with a mental health professional for evaluation; professional judgment guides timing for referral letters (common period ~3 months but variable).
    Qualified Mental Health Professional (per WPATH SOC-8) definition
    Qualification baselineLicensed by their statutory body and hold, at minimum, a master’s degree or equivalent training in a clinical field relevant to this role, granted by a nationally accredited institution.
    Clinical capabilitiesAble to identify coexisting mental health or psychosocial concerns and distinguish these from gender dysphoria, assess capacity to consent, and evaluate clinical aspects of gender dysphoria and incongruence.
    Professional development and collaborationUndergo continuing education in transgender health and liaise with multidisciplinary professionals for consultation and referral as needed.
    Surgical credential noteWPATH SOC-8 also describes surgeon credentials: documented training/supervision in gender-affirming procedures, maintenance of active practice, continuing education, and outcome tracking.